Recent Finacing
Recent Raise
Allegro Diagnostics develops a gene-expression-based molecular diagnostic platform that analyzes non-malignant airway epithelial cells ("field of injury") to detect lung cancer and augment bronchoscopy via its BronchoGen test.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors